P.G. Hultin, R.M. Buffie / Carbohydrate Research 322 (1999) 14–25
23
Methyl 2,3-di-O-benzoyl-4,6-dideoxy-h-
lyxo - hexopyranosyl - (13) - 2 - acetamido - 4,
6-O-benzylidene-2-deoxy-h- -glucopyranoside
L
-
mixture (gradient elution, 1020% EtOAc–
hexanes) afforded 15 (79 mg, 13%) and 17
(326 mg, 54%), which crystallized on standing:
mp: 78–79.2 °C; [h]D +57.3° (c 1.03, CHCl3);
1H NMR (CDCl3): l 1.30 (tr, 3 H, J 7.5 Hz),
1.39 (dd, 3 H, J6,F 1.0, J5,6 6.1 Hz, H-6), 2.57
(br s, OH), 2.73 (app q, 2 H, Japp 7.4 Hz), 3.44
(ddq, 1 H, J5,F 2.5, J4,5 9.2 Hz, H-5), 3.57
(ddd, 1 H, J2,3 3.0, J3,4 9.0, J3,F 13.9 Hz, H-3),
4.11 (m, 1 H, H-2), 4.46 (ddd, 1 H, J4,F 50.7
Hz, H-4), 4.55 (br s, 1 H, H-1), 4.70 (d, 1 H,
J 11.9 Hz), 4.80 (d, 1 H, J 11.9 Hz), 7.31–7.37
(m, 5 H); 13C NMR (CDCl3): l 14.96, 17.45,
25.47, 71.09 (d, JC,F 9.4 Hz), 72.18, 74.03
(d, JC,F 24.5 Hz), 79.06 (d, JC,F 15.1 Hz),
83.25, 93.02 (d, JC,F 180.7 Hz), 127.80, 128.02,
128.50, 137.35; Anal. Calcd for C15H21-
FO3S: C, 59.98; H, 7.05. Found: C, 59.70; H,
7.20.
D
(27).—Thioglycoside 5 (200 mg, 0.50 mmol),
methyl 2-acetamido-4,6-O-benzylidene-2-de-
oxy-a- -glucopyranoside [30] (194 mg, 0.60
D
,
mmol) and powdered, freshly activated 4 A
molecular sieves (500 mg) were placed in a dry
two-necked flask fitted with a septum, a three-
way gas inlet valve and a magnetic stirring bar
and left overnight at 0.1 torr. The flask was
then flushed with argon, dry CH2Cl2 (4.0 mL)
was added, and the mixture was vigorously
stirred for 1 h. Recrystallized N-iodosuccin-
imide (146 mg, 0.65 mmol) was added, fol-
lowed by TfOH (5.8 mL, 0.065 mmol). TLC
analysis indicated complete consumption of
the donor after 15 min. The mixture was
filtered through Celite into 50% satd aq
Na2S2O3 (5 mL) in a separatory funnel. The
filter cake was washed with several portions of
CH2Cl2 (45 mL total), which were also added
to the separatory funnel. The mixture was
shaken until all color was discharged, and the
phases were separated. The organic layer was
washed with satd aq NaHCO3 (5 mL), water
(5 mL) and brine (5 mL), then dried and
concentrated. Chromatography of the solid
residue (3:1 CH2Cl2 –EtOAc) afforded 27 (272
mg, 82%) as white crystals: mp 230–231 °C;
[h]D +32.0° (c 0.5, CHCl3); 1H NMR
(CDCl3): l 0.76 (d, 3 H, J5%,6% 6.2 Hz, H-6%),
1.78–1.98 (m, 2 H, H-4%, H-4a%), 2.17 (s, 3 H)
3.40 (s, 3 H), 3.69 (dd, 1 H, J4,5 8.6, J3,4 9.8
Hz, H-4), 3.76–3.90 (m, 2 H, H-5%, H-6), 3.95
(dd, 1 H, J2,3 10.0 Hz, H-3), 4.18–4.32 (m, 2
H, H-5, H-6a), 4.47 (ddd, 1 H, J1,2 3.7, JNH,2
10.0 Hz, H-2), 4.66 (d, 1 H, H-1), 5.17–5.20
(m, 2 H, H-1%, H-2%), 5.54 (ddd, 1 H, J2%,3% 3.0,
J4%,3% 5.1, J4a%,3% 11.8 Hz, H-3%), 5.57 (s, 1 H),
5.77 (d, 1 H, NH), 7.30–7.37 (m, 5 H), 7.43–
7.53 (m, 5 H), 7.59 (m, 1 H), 7.89 (m, 2 H),
8.07 (m, 2 H); 13C NMR (CDCl3): l 20.35,
23.51, 33.71, 53.15, 55.17, 63.11, 64.25, 67.76,
68.97, 69.40, 76.06, 80.32, 99.08 (1JC,H 171.6
Hz), 99.43 (1JC,H 170.2 Hz), 102.15, 126.42,
128.13, 128.21, 128.40, 129.09, 129.56, 129.67,
129.94, 130.00, 132.91, 133.14, 137.22, 165.40,
165.62, 170.57; Anal. Calcd for C36H39NO11:
C, 65.35; H, 5.94; N, 2.12. Found: C, 65.68;
H, 6.21, N, 2.09.
Ethyl 2-O-benzoyl-3-O-benzyl-4-deoxy-4-
fluoro-1-thio-i- -rhamnopyranoside (18).—A
L
mixture of 17 (200 mg, 0.67 mmol), dry
pyridine (2.5 mL) and DMAP (8 mg, 0.07
mmol) was treated with benzoyl chloride (230
mL, 1.98 mmol). The reaction was stirred for
2.5 h at rt. It was then cooled on a water bath,
while cold water (2.5 mL) was added drop-
wise. The mixture was stirred for 1 h more,
and then diluted with ether (30 mL). The
phases were separated, and the organic layer
was washed with 1.2 N HCl (4×5 mL) and
satd aq Na2CO3 (5 mL). Drying and evapora-
tion (finishing on a vacuum pump to remove
all traces of solvent) provided 270 mg (99%)
of 18 as a pure oil: [h]D +141.1° (c 1.00,
1
CHCl3); H NMR (CDCl3): l 1.28 (tr, 3 H, J
7.4 Hz), 1.48 (dd, 3 H, J6,F 1.3, J5,6 6.1 Hz,
H-6), 2.65–2.82 (m, 2 H), 3.56 (ddq, 1 H, J5,F
3.2, J4,5 9.2 Hz, H-5), 3.75 (ddd, 1 H, J2,3 3.7,
J3,4 9.2, J3,F 12.9 Hz, H-3), 4.47 (ddd, 1 H, J4,F
50.5 Hz, H-4), 4.62 (d, 1 H, J 12.2 Hz), 4.76
(d, 1 H, J1,2 1.0 Hz, H-1), 4.81 (d, 1 H, J 12.2
Hz), 5.88 (ddd, 1 H, J2,F 2.7 Hz, H-2), 7.28–
7.33 (m, 5 H), 7.45 (m, 2 H), 7.57 (m, 1 H),
8.10 (m, 2 H); 13C NMR (CDCl3): l 14.83,
17.79, 25.64, 71.20 (d, JC,F 9.2 Hz), 71.47,
74.40 (d, JC,F 24.0 Hz), 77.72 (d, JC,F 18.2 Hz),
82.40, 92.29 (d, JC,F 182.1 Hz), 127.74, 128.33,
129.48, 130.03, 133.18, 137.38, 165.72; Anal.
Calcd for C22H25FO4S: C, 65.33; H, 6.23.
Found: C, 65.60; H, 6.67.